Januvia and Daliresp drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Januvia (sitagliptin phosphate) and Daliresp (roflumilast). Common drug interactions include cardiac arrest among females and weight decreased among males.

The phase IV clinical study analyzes what interactions people have when they take Januvia and Daliresp. It is created by eHealthMe based on reports of 59 people who take the same drugs from the FDA, and is updated regularly.

What is Januvia?

Januvia has active ingredients of sitagliptin phosphate. It is often used in diabetes. eHealthMe is studying from 72,818 Januvia users. Check the latest studies of Januvia.

What is Daliresp?

Daliresp has active ingredients of roflumilast. It is often used in chronic obstructive pulmonary disease. eHealthMe is studying from 4,722 Daliresp users. Check the latest studies of Daliresp.

On Jul, 14, 2026

59 people who take Januvia and Daliresp together, and have interactions are studied.

What are the common drug interactions of Januvia and Daliresp, by gender? *:

female:

Cardiac arrest
Cardiac disorder
Contusion (a type of hematoma of tissue in which capillaries)
Depression
Disorientation (disability in which the senses of time, direction, and recognition of people and places)
Emotional disorder
Feeling hot
Flushing (the warm, red condition of human skin)
Hallucination (an experience involving the perception of something not present)
Headache (pain in head)

male:

Weight decreased
Death
Diarrhoea
Dizziness
Feeling jittery
Haemoglobin decreased
Heart rate increased
Palpitations (feelings or sensations that your heart is pounding or racing)
Peripheral swelling
Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)

What are the common drug interactions of Januvia and Daliresp, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Depression
Disorientation (disability in which the senses of time, direction, and recognition of people and places)
Fear
Hallucination (an experience involving the perception of something not present)
Suicidal ideation

50-59:

Weight decreased
Pneumonia
Infection
Arthralgia (joint pain)
Back pain
Blood glucose increased
Bursitis (inflammation of a bursa, typically one in the knee, elbow, or shoulder)
Cough
Diarrhoea
Dyspnoea (difficult or laboured respiration)

60+:

Dyspnoea (difficult or laboured respiration)
Fatigue (feeling of tiredness)
Abdominal distension
Adverse event
Anaemia (lack of blood)
Cardiac failure congestive
Decreased appetite
Diarrhoea
Dizziness
Haemoglobin decreased

What are the existing conditions these people have? *

Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 17 people, 28.81%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 16 people, 27.12%
Multiple Myeloma (cancer of the plasma cells): 9 people, 15.25%
Pain: 5 people, 8.47%
High Blood Pressure: 5 people, 8.47%
Type 2 Diabetes: 4 people, 6.78%
Stress And Anxiety: 4 people, 6.78%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 4 people, 6.78%
High Blood Cholesterol: 4 people, 6.78%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 6.78%

* Approximation only. Some reports may have incomplete information.

Do you take Januvia and Daliresp?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously